Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations

The benefit of second-line chemotherapy (L2) over standard first-line (L1) gemcitabine plus cisplatin (GEMCIS) or oxaliplatin (GEMOX) chemotherapy in advanced biliary tract cancer (aBTC) is unclear. Our aim was to identify and validate prognostic factors for overall survival (OS) with L2 in aBTC to...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2019-04, Vol.111, p.94-106
Hauptverfasser: Neuzillet, Cindy, Casadei Gardini, Andrea, Brieau, Bertrand, Vivaldi, Caterina, Smolenschi, Cristina, Brandi, Giovanni, Tougeron, David, Filippi, Roberto, Vienot, Angélique, Silvestris, Nicola, Pointet, Anne-Laure, Lonardi, Sara, Rousseau, Benoît, Scartozzi, Mario, Dahan, Laetitia, Aprile, Giuseppe, Boussaha, Tarek, Malka, David, Crusz, Shantini M., Le Sourd, Samuel, Meurisse, Aurélia, Lièvre, Astrid, Vernerey, Dewi, Evesque, Ludovic, Heurgué, Alexandra, Desramé, Jérôme, Lecomte, Thierry, Cacheux, Wulfran, Bachet, Jean-Baptiste, Phelip, Jean-Marc, Hautefeuille, Vincent, Hammoudi, Nassim, Mary, Florence, Locher, Christophe, Bidault-Thirot, Anne, Marthey, Lysiane, Touchefeu, Yann, Moulin, Valérie, Zaanan, Aziz, Taïeb, Julien, Casagrande, Mariaelena, Murgioni, Sabina, Santini, Daniele, Fornaro, Lorenzo, Montagnani, Francesco, Leone, Francesco, Faloppi, Luca, Giommoni, Elisa, Lutrino, Stefania Eufemia, Palloni, Andrea, Brunetti, Oronzo, Bergamo, Francesca, Vasile, Enrico, Propper, David
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!